Review: taking Doxycycline hyclate and Macrobid together


Summary

Drug interactions are reported among people who take Doxycycline hyclate and Macrobid together. This review analyzes the effectiveness and drug interactions between Doxycycline hyclate and Macrobid. It is created by eHealthMe based on reports of 94 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Doxycycline hyclate and Macrobid >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Doxycycline Hyclate

Doxycycline hyclate has active ingredients of doxycycline hyclate. It is often used in acne. (latest outcomes from Doxycycline hyclate 2,759 users)

Macrobid

Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. (latest outcomes from Macrobid 3,799 users)

On Aug, 21, 2016

94 people who take Doxycycline Hyclate, Macrobid are studied.


Number of reports submitted per year:

Doxycycline hyclate and Macrobid drug interactions.

Drug effectiveness over time:

Doxycycline Hyclate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Macrobid:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Doxycycline Hyclate:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)
Macrobid:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Doxycycline Hyclate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Macrobid:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • abdominal pain
  • anaemia
  • pain
  • adrenal insufficiency
  • alanine aminotransferase increased
  • anhedonia
  • anxiety
  • aspartate aminotransferase increased
  • atelectasis
  • bone fragmentation
1 - 6 months:
  • swelling
  • visual impairment
  • adverse event
  • conjunctivitis
  • nodule
  • pneumonia
6 - 12 months:
  • adverse event
  • conjunctivitis
  • nodule
  • pneumonia
  • swelling
  • visual impairment
not specified:
  • urinary tract infection
  • pain
  • dyspnoea
  • oedema peripheral
  • anaemia
  • fall
  • pain in extremity
  • anxiety
  • asthenia
  • infection

Most common drug interactions by gender *:

female:
  • urinary tract infection
  • pain
  • oedema peripheral
  • dyspnoea
  • anaemia
  • fall
  • infection
  • pain in extremity
  • paraesthesia
  • asthenia
male:
  • haemorrhoids
  • pain
  • anxiety
  • balance disorder
  • convulsion
  • diarrhoea
  • dizziness
  • dyspnoea
  • dyspnoea paroxysmal nocturnal
  • dysuria

Most common drug interactions by age *:

0-1:
  • fallot's tetralogy
  • maternal exposure during pregnancy
20-29:
  • constipation
  • dyspnoea
  • infection
  • oedema peripheral
  • osteomyelitis
  • osteonecrosis of jaw
  • pain
  • pain in extremity
  • paraesthesia
  • thrombocytopenia
30-39:
  • chills
  • diarrhoea
  • drug hypersensitivity
  • feeling hot
  • gastrointestinal infection
  • headache
  • lung infection
  • nausea
  • pain
  • productive cough
40-49:
  • chronic obstructive pulmonary disease
  • pneumonia
  • pain
  • fatigue
  • weight increased
  • abdominal pain
  • anaemia
  • drug ineffective
  • fall
  • oedema peripheral
50-59:
  • asthenia
  • urinary tract infection
  • anxiety
  • injury
  • pain
  • adrenal neoplasm
  • anaemia
  • ankle fracture
  • arthralgia
  • atrial fibrillation
60+:
  • dyspnoea
  • injury
  • anxiety
  • constipation
  • dizziness
  • pain
  • spinal osteoarthritis
  • vomiting
  • abdominal pain
  • cough

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Doxycycline hyclate and Macrobid?

Can you answer these questions?

More questions for: Doxycycline hyclate, Macrobid

You may be interested in these reviews

More reviews for: Doxycycline hyclate, Macrobid

On eHealthMe, Doxycycline hyclate (doxycycline hyclate) is often used to treat acne. Macrobid (nitrofurantoin; nitrofurantoin, macrocrystalline) is often used to treat urinary tract infection. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.